Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.

[1]  Yuzhou Xue,et al.  Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats , 2021, Biochemical and Biophysical Research Communications.

[2]  Han Xiao,et al.  The Role of the Inflammasome in Heart Failure , 2021, Frontiers in Physiology.

[3]  Ray-Jade Chen,et al.  Aqueous extract of Solanum nigrum attenuates Angiotensin-II induced cardiac hypertrophy and improves cardiac function by repressing protein kinase C-ζ to restore HSF2 deSUMOlyation and Mel-18-IGF-IIR signaling suppression. , 2021, Journal of ethnopharmacology.

[4]  M. Vázquez-Carrera,et al.  Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far. , 2021, Life sciences.

[5]  Jian-Mei Li,et al.  p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis , 2021, Antioxidants.

[6]  M. El-Sherbiny,et al.  Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis. , 2021, International immunopharmacology.

[7]  L. Barakat,et al.  Diacerein ameliorates kidney injury induced by cisplatin in rats by activation of Nrf2/Ho-1 pathway and Bax down-regulation , 2021, Saudi journal of biological sciences.

[8]  A. Alizadeh,et al.  Role of oxytocin and c-Myc pathway in cardiac remodeling in neonatal rats undergoing cardiac apical resection. , 2021, European journal of pharmacology.

[9]  Daniel N. Meijles,et al.  The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension. , 2021, Clinical science.

[10]  C. Hengstenberg,et al.  Myocardial Angiotensin Metabolism in End-Stage Heart Failure. , 2021, Journal of the American College of Cardiology.

[11]  G. Liang,et al.  Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodeling. , 2021, Translational research : the journal of laboratory and clinical medicine.

[12]  G. Batiha,et al.  Diacerein protects rats with liver ischemia/reperfusion damage: Down-regulation of TLR4/ NFκ-B signaling pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  H. Ishikawa,et al.  Epoxyquinophomopsins A and B from endophytic fungus Phomopsis sp. and their activity against tyrosine kinase , 2020, Journal of natural medicines.

[14]  A. Abbas,et al.  Diacerein: Recent insight into pharmacological activities and molecular pathways. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  A. Sposito,et al.  Diacerein: A potential multi-target therapeutic drug for COVID-19 , 2020, Medical Hypotheses.

[16]  B. Knebel,et al.  Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis , 2020, Scientific Reports.

[17]  Xiang Hu,et al.  Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3 , 2020, Circulation research.

[18]  J. Auwerx,et al.  Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress , 2019, Circulation research.

[19]  R. Touyz,et al.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure , 2019, Pharmacological Reviews.

[20]  N. Zhang,et al.  Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction , 2019, Cardiovascular diabetology.

[21]  M. Sorrentino.  The Evolution from Hypertension to Heart Failure. , 2019, Heart failure clinics.

[22]  Y. Hafez,et al.  Diacerein protects against glycerol-induced acute kidney injury: Modulating oxidative stress, inflammation, apoptosis and necroptosis. , 2019, Chemico-biological interactions.

[23]  A. Deussen,et al.  Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension , 2019, Critical reviews in food science and nutrition.

[24]  Yu-Ming Kang,et al.  Silencing salusin β ameliorates heart failure in aged spontaneously hypertensive rats by ROS-relative MAPK/NF-κB pathways in the paraventricular nucleus. , 2019, International journal of cardiology.

[25]  G. Liang,et al.  Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling , 2018, Hypertension.

[26]  Sijin Zhang,et al.  Effects of microRNA‐494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c‐myc through the p38 MAPK signaling pathway , 2018, Journal of cellular biochemistry.

[27]  Huijun Sun,et al.  Hepatoprotective effect of rhein against methotrexate‐induced liver toxicity , 2018, European journal of pharmacology.

[28]  S. A. Abdel-Gaber,et al.  Mechanism mediating the protective effect of diacerein in ischemia‐reperfusion‐induced testicular injury in rats , 2018, Life sciences.

[29]  Wei Wang,et al.  Improved heart failure by Rhein lysinate is associated with p38MAPK pathway. , 2018, Experimental and therapeutic medicine.

[30]  Weihui Chen,et al.  Retraction notice to "Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell carcinoma suppresses EMT-mediated metastasis and tumor-initiating properties through MAPK signaling" [Biochem. Biophys. Res. Commun. 484 (4) (2017) 801-807]. , 2018, Biochemical and biophysical research communications.

[31]  N. Chattipakorn,et al.  Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin‐resistant rats , 2018, Free radical biology & medicine.

[32]  Shuyong Wei.  Yin-yang regulating effects of cancer-associated genes, proteins, and cells: An ancient Chinese concept in vogue in modern cancer research. , 2017, Bioscience trends.

[33]  G. Salles,et al.  Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial , 2017, Diabetes Care.

[34]  O. Abdallah,et al.  Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation , 2017, International journal of nanomedicine.

[35]  C. K. Das,et al.  Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. , 2017, Cancer letters.

[36]  E. Martínez-Abundis,et al.  Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control , 2017, Archives of endocrinology and metabolism.

[37]  J. Molkentin,et al.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs). , 2016, Journal of molecular and cellular cardiology.

[38]  S. Jaganathan,et al.  Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer , 2016, Oncogene.

[39]  J. Butler,et al.  Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure. , 2016, Journal of Cardiac Failure.

[40]  M. Grant,et al.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. , 2016, Circulation research.

[41]  C. Cooper,et al.  Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO , 2016, Drugs & Aging.

[42]  R. Touyz,et al.  Angiotensin II and Vascular Injury , 2014, Current Hypertension Reports.

[43]  Hui-Hua Li,et al.  Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. , 2014, Cardiovascular research.

[44]  Y. Singh,et al.  Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. , 2013, Journal of biomedical nanotechnology.

[45]  N. Isern,et al.  C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle. , 2013, Journal of molecular and cellular cardiology.

[46]  C. Kilkenny,et al.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.

[47]  Yibin Wang,et al.  Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. , 2010, The Journal of clinical investigation.

[48]  T. Abraham,et al.  TIMP2 Deficiency Accelerates Adverse Post–Myocardial Infarction Remodeling Because of Enhanced MT1-MMP Activity Despite Lack of MMP2 Activation , 2010, Circulation research.

[49]  T. Pal,et al.  Bioequivalence Study of Two Capsule Formulations Containing Diacerein 50 mg in Healthy Human Subjects , 2008, Arzneimittel-Forschung (Drug Research).

[50]  S. Bishop,et al.  The c-myc proto-oncogene regulates cardiac development in transgenic mice , 1990, Molecular and cellular biology.

[51]  S. Coughlin,et al.  Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Cuzzocrea,et al.  Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. , 2015, Pharmacological research.